Seema Sangwan, MD
Internal Medicine · San Mateo
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 18
- 5 carriers
- Office
- 1
Offices
1 location · Seema Sangwan MD Inc A California Professional Corporation · 3 clinicians in this group
Looking this up.
Hospitals listed: 058123 · El Camino Health · Mills-Peninsula Medical Center. That is not proof they admit you there this week.
Plans that list them
18 plans · 5 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Sangwan’s office at (408) 900-8077 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
18 of 18 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence A78098 · Current
Licensed to practise in California · since 2002 · expires 2027-09-30 · Maharshi Dayanand University P.T. Bhagwat Dayal Sharma Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
- Peninsula Medical CenterBurlingame, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.139, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.242, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Peninsula Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.139 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.242 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.21 (0.27 to 2.15) · 1,258 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.81 (0.51 to 1.1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 155.44 (112.67 to 198.21) · 90 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.5 · 32 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 82 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 188 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9 · 473 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.8 · 342 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.4 · 485 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 3,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.4) · 6,904 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,052 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.41 (1.43 to 5.39) · 1,695 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.72 (0.17 to 3.28) · 665 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,545 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.1 (1.3 to 12.9) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.96 (2.63 to 9.29) · 653 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.08) · 418 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.14 (0 to 0.78) · 5,539 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 192 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.215 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.263 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.74 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 300 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19 · 702 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 1.2 · 207 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13.6 · 531 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 24.3 · 343 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 449 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.5 (2.8 to 7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.6 (6.7 to 13.7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 189 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11 · 45 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 117 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.7 to 17.2) · 584 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 764 cases | No different | Jan 2024 – Dec 2024 |
What patients said (523 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$52,910
Medicare paid this office $52,910 for 109 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 69 | $17,077 | $112 |
| Short return visit (20+ min) | 77 | $13,477 | $82 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 34 | $5,310 | $156 |
| Telephone medical discussion with physician, 5-10 minutes | 39 | $2,977 | $50 |
| Telephone medical discussion with physician, 11-20 minutes | 22 | $2,022 | $75 |
See all 8 services
| Return visit (30+ min) | 69 | $17,077 | $112 |
| Short return visit (20+ min) | 77 | $13,477 | $82 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 34 | $5,310 | $156 |
| Telephone medical discussion with physician, 5-10 minutes | 39 | $2,977 | $50 |
| Telephone medical discussion with physician, 11-20 minutes | 22 | $2,022 | $75 |
| New patient visit (45+ min) | 13 | $1,569 | $121 |
| Administration of influenza virus vaccine | 12 | $465 | $39 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 11 | $153 | $13 |
Who their Medicare patients are
109 Original Medicare patients in 2024. Average age 77 · Women 67% · Health risk score 1.06. At or below the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 71% · Cancer 24% · Coronary heart disease 20% · Diabetes 17% · Atrial fibrillation 17% · Depression 17% · Chronic kidney disease 15% · Heart failure 13% · COPD 13%.
The office billed $137,153, Medicare allowed $68,059 and paid $52,910; for 561 services of 26 kinds; $2,893 of it was for drugs given in the office and $50,016 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 109 | 561 | 77 | 1.06 | $137,153 | $52,910 |
| 2023 | 82 | 444 | 78 | 1.02 | $101,212 | $40,124 |
| 2022 | 61 | 312 | 76 | 0.94 | $70,073 | $28,920 |
| 2021 | 59 | 316 | 77 | 0.94 | $56,988 | $28,813 |
| 2020 | 76 | 357 | 76 | 1.24 | $54,505 | $25,918 |
| 2019 | 136 | 485 | 78 | 1.27 | $86,367 | $37,719 |
| 2018 | 247 | 1,034 | 76 | 1.31 | $178,812 | $79,303 |
| 2017 | 259 | 1,093 | 77 | 1.37 | $188,895 | $86,955 |
| 2016 | 294 | 1,281 | 77 | 1.58 | $212,835 | $101,795 |
| 2015 | 232 | 1,008 | 76 | 1.31 | $177,899 | $84,475 |
| 2014 | 316 | 1,097 | 77 | 1.72 | $223,821 | $106,247 |
| 2013 | 47 | 149 | 79 | 1.82 | $34,360 | $14,154 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 9 services
| Return visit (30+ min) | 46 | $10,030 | $107 |
| Short return visit (20+ min) | 56 | $8,790 | $77 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 37 | $5,682 | $154 |
| Telephone medical discussion with physician, 11-20 minutes | 32 | $4,242 | $74 |
| Telephone medical discussion with physician, 21-30 minutes | 11 | $1,684 | $120 |
| Influenza vaccine split virus, preservative free | 12 | $863 | $72 |
| Short return visit | 14 | $822 | $51 |
| Telephone medical discussion with physician, 5-10 minutes | 20 | $672 | $27 |
| Administration of influenza virus vaccine | 13 | $474 | $36 |
2022: 6 services
| Return visit (30+ min) | 35 | $7,849 | $108 |
| Short return visit (20+ min) | 40 | $6,590 | $78 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 24 | $3,802 | $158 |
| Telephone medical discussion with physician, 11-20 minutes | 15 | $1,030 | $64 |
| Influenza vaccine split virus, preservative free | 11 | $754 | $69 |
| Administration of influenza virus vaccine | 13 | $483 | $37 |
2021: 6 services
| Return visit (30+ min) | 40 | $10,758 | $110 |
| Short return visit (20+ min) | 40 | $5,650 | $74 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 25 | $4,023 | $161 |
| Influenza vaccine split virus, preservative free | 11 | $718 | $65 |
| Administration of influenza virus vaccine | 19 | $407 | $21 |
| Annual depression screening, 5 to 15 minutes | 14 | $332 | $24 |
2020: 6 services
| Return visit (30+ min) | 41 | $5,787 | $88 |
| Short return visit (20+ min) | 46 | $5,164 | $57 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 15 | $2,110 | $141 |
| Influenza vaccine split virus, preservative free | 20 | $1,200 | $60 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 13 | $1,185 | $52 |
| Administration of influenza virus vaccine | 30 | $638 | $21 |
2019: 8 services
| Short return visit (20+ min) | 67 | $9,149 | $61 |
| Return visit (30+ min) | 68 | $7,342 | $74 |
| Long return visit (40+ min) | 19 | $5,813 | $119 |
| Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 16 | $3,141 | $196 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 19 | $2,624 | $138 |
| Influenza vaccine split virus, preservative free | 18 | $1,035 | $54 |
| Short return visit | 12 | $562 | $37 |
| Administration of influenza virus vaccine | 24 | $505 | $20 |
2018: 12 services
| Return visit (30+ min) | 145 | $22,340 | $87 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 94 | $12,659 | $135 |
| Short return visit (20+ min) | 131 | $12,030 | $52 |
| Long return visit (40+ min) | 45 | $9,017 | $127 |
| Pneumococcal vaccine, 13-valent | 18 | $3,557 | $198 |
| Influenza vaccine split virus, preservative free | 67 | $3,457 | $52 |
| Administration of influenza virus vaccine | 71 | $1,796 | $25 |
| New patient visit (45+ min) | 13 | $1,675 | $129 |
| Pneumococcal vaccine, 23-valent | 15 | $1,584 | $106 |
| Administration of pneumococcal vaccine | 33 | $835 | $25 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 36 | $510 | $13 |
| Short return visit | 13 | $407 | $29 |
2017: 13 services
| Return visit (30+ min) | 137 | $22,531 | $93 |
| Short return visit (20+ min) | 166 | $18,403 | $56 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 121 | $16,706 | $138 |
| Pneumococcal vaccine, 13-valent | 29 | $5,339 | $184 |
| Influenza vaccine split virus, preservative free | 61 | $2,978 | $47 |
| New patient visit (45+ min) | 19 | $2,286 | $120 |
| Administration of influenza virus vaccine | 63 | $2,093 | $32 |
| Long return visit (40+ min) | 12 | $1,618 | $135 |
| Administration of pneumococcal vaccine | 41 | $1,320 | $32 |
| Pneumococcal vaccine, 23-valent | 12 | $1,128 | $94 |
| New patient visit (30+ min) | 12 | $899 | $75 |
| Short return visit | 12 | $504 | $39 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 22 | $359 | $15 |
2016: 17 services
| Short return visit (20+ min) | 188 | $23,739 | $63 |
| Return visit (30+ min) | 135 | $19,596 | $90 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 125 | $17,328 | $139 |
| Pneumococcal vaccine, 13-valent | 40 | $7,020 | $176 |
| New patient visit (45+ min) | 47 | $6,395 | $136 |
| Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 20 | $4,038 | $202 |
| Administration of influenza virus vaccine | 94 | $3,014 | $32 |
| Influenza vaccine split virus, preservative free | 68 | $2,784 | $41 |
| Established patient custodial care facility, group care, or assisted living visit, typically 40 minutes | 12 | $2,452 | $107 |
| Administration of pneumococcal vaccine | 56 | $1,797 | $32 |
| Pneumococcal vaccine, 23-valent | 19 | $1,675 | $88 |
| Long return visit (40+ min) | 11 | $1,622 | $135 |
| New patient visit (30+ min) | 18 | $1,449 | $81 |
| Advance care planning, first 30 minutes | 14 | $1,130 | $75 |
| Short return visit | 22 | $922 | $37 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 31 | $461 | $14 |
| Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin) | 17 | $265 | $16 |
2015: 12 services
| Return visit (30+ min) | 125 | $23,640 | $92 |
| Short return visit (20+ min) | 126 | $13,159 | $64 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 89 | $12,411 | $139 |
| Pneumococcal vaccine, 13-valent | 70 | $12,048 | $170 |
| New patient visit (45+ min) | 64 | $8,682 | $136 |
| Administration of influenza virus vaccine | 70 | $2,286 | $32 |
| Long return visit (40+ min) | 15 | $1,908 | $127 |
| Administration of pneumococcal vaccine | 55 | $1,800 | $32 |
| New patient visit (30+ min) | 14 | $1,177 | $84 |
| Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin) | 67 | $1,053 | $15 |
| Short return visit | 15 | $614 | $41 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 34 | $597 | $17 |
2014: 17 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 117 | $27,611 | $92 |
| New patient visit (45+ min) | 71 | $10,461 | $147 |
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 45 | $10,257 | $83 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 53 | $9,542 | $180 |
| Hospital discharge day management, more than 30 minutes | 83 | $8,128 | $97 |
| Return visit (30+ min) | 49 | $7,867 | $100 |
| Critical care, first 30-74 minutes | 20 | $6,645 | $195 |
| Short return visit (20+ min) | 39 | $4,032 | $68 |
| New patient visit (30+ min) | 31 | $2,811 | $91 |
| New patient visit (60+ min) | 14 | $2,648 | $189 |
| Initial nursing facility care with high level of medical decision making, per day 50 minutes or more | 14 | $2,101 | $150 |
| Long return visit (40+ min) | 11 | $1,876 | $134 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 19 | $1,667 | $64 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 18 | $1,569 | $63 |
| Administration of influenza virus vaccine | 43 | $1,345 | $31 |
| Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin) | 40 | $604 | $15 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 13 | $226 | $16 |
2013: 3 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 27 | $6,268 | $90 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 15 | $2,620 | $175 |
| Hospital discharge day management, more than 30 minutes | 11 | $1,039 | $94 |
Drugs they prescribed that Part D paid
$163,329
Pharmacies billed $163,329 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
1,189 generic and fewer than 11 brand-name prescriptions · $163,329 in drug cost · 59 antibiotic prescriptions to 25 people · 14 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Wixela Inhub | 11 | $1,463 | $133 |
| Synthroid | 17 | $1,370 | $81 |
| Atorvastatin | 81 | $993 | $12 |
| Losartan | 60 | $985 | $16 |
| Rosuvastatin | 65 | $948 | $15 |
See all 31 drugs
| Wixela Inhub | 11 | $1,463 | $133 |
| Synthroid | 17 | $1,370 | $81 |
| Atorvastatin | 81 | $993 | $12 |
| Losartan | 60 | $985 | $16 |
| Rosuvastatin | 65 | $948 | $15 |
| Levothyroxine | 59 | $772 | $13 |
| Olmesartan Medoxomil | 23 | $746 | $32 |
| Celecoxib | 25 | $709 | $28 |
| Metformin Hcl Er | 31 | $645 | $21 |
| Omeprazole | 27 | $581 | $22 |
| Amlodipine Besylate | 68 | $573 | $8 |
| Baclofen | 15 | $475 | $32 |
| Ezetimibe | 14 | $428 | $31 |
| Gabapentin | 26 | $414 | $16 |
| Diclofenac | 23 | $411 | $18 |
| Verapamil Er | 11 | $399 | $36 |
| Montelukast | 15 | $378 | $25 |
| Pantoprazole | 20 | $362 | $18 |
| Metformin | 12 | $281 | $23 |
| Fluoxetine | 28 | $250 | $9 |
| Trazodone | 27 | $202 | $7 |
| Clopidogrel | 11 | $200 | $18 |
| Lisinopril | 30 | $195 | $6 |
| Pravastatin | 15 | $189 | $13 |
| Paroxetine | 11 | $185 | $17 |
| Donepezil | 14 | $126 | $9 |
| Simvastatin | 12 | $125 | $10 |
| Nitrofurantoin Mono-Macro | 13 | $89 | $7 |
| Alendronate | 14 | $83 | $6 |
| Mupirocin | 15 | $71 | $5 |
| Ciprofloxacin | 14 | $36 | $3 |
Year by year
| 2024 | 1,316 | 123 | None | None | $163,329 |
| 2023 | 1,022 | 93 | None | 7% | $83,748 |
| 2022 | 907 | 76 | None | None | $66,071 |
| 2021 | 1,065 | 81 | 1% (12) | 14% | $90,089 |
| 2020 | 880 | 82 | None | None | $81,146 |
| 2019 | 1,337 | 166 | None | None | $94,933 |
| 2018 | 2,383 | 207 | 2% (35) | 15% | $175,113 |
| 2017 | 3,064 | 232 | 2% (68) | None | $229,194 |
| 2016 | 2,741 | 253 | 4% (110) | 17% | $152,237 |
| 2015 | 1,608 | 202 | 6% (102) | None | $88,842 |
| 2014 | 492 | 167 | 9% (46) | None | $38,054 |
| 2013 | 41 | 23 | 34% (14) | None | $2,022 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 30 drugs
| Wixela Inhub | 11 | $2,325 | $211 |
| Aripiprazole | 17 | $2,069 | $122 |
| Rosuvastatin | 31 | $1,338 | $43 |
| Synthroid | 14 | $1,323 | $94 |
| Atorvastatin | 69 | $1,115 | $16 |
| Losartan | 52 | $1,078 | $21 |
| Celecoxib | 14 | $984 | $70 |
| Metformin Hcl Er | 33 | $735 | $22 |
| Levothyroxine | 30 | $726 | $24 |
| Olmesartan Medoxomil | 17 | $594 | $35 |
| Sertraline | 33 | $492 | $15 |
| Metformin | 14 | $491 | $35 |
| Trazodone | 33 | $464 | $14 |
| Chlorthalidone | 11 | $455 | $41 |
| Amlodipine Besylate | 47 | $391 | $8 |
| Gabapentin | 26 | $334 | $13 |
| Fluticasone Propionate | 15 | $324 | $22 |
| Donepezil | 19 | $264 | $14 |
| Albuterol Sulfate Hfa | 11 | $238 | $22 |
| Omeprazole | 23 | $236 | $10 |
| Valsartan | 13 | $225 | $17 |
| Lisinopril | 22 | $222 | $10 |
| Simvastatin | 17 | $218 | $13 |
| Pravastatin | 14 | $214 | $15 |
| Paroxetine | 12 | $178 | $15 |
| Fluoxetine | 13 | $143 | $11 |
| Paxlovid (Eua) | 12 | $127 | $11 |
| Hydrochlorothiazide | 15 | $97 | $6 |
| Naproxen | 13 | $95 | $7 |
| Baclofen | 12 | $71 | $6 |
2022: 26 drugs
| Eliquis | 15 | $11,034 | $736 |
| Aripiprazole | 20 | $7,632 | $382 |
| Memantine | 15 | $2,075 | $138 |
| Rosuvastatin | 20 | $1,572 | $79 |
| Losartan | 41 | $926 | $23 |
| Atorvastatin | 53 | $809 | $15 |
| Fluticasone Propionate | 18 | $730 | $41 |
| Levothyroxine | 30 | $703 | $23 |
| Donepezil | 21 | $561 | $27 |
| Pravastatin | 25 | $538 | $22 |
| Tamsulosin | 21 | $525 | $25 |
| Amlodipine Besylate | 44 | $448 | $10 |
| Glipizide Er | 11 | $426 | $39 |
| Metformin | 17 | $381 | $22 |
| Fluoxetine | 18 | $344 | $19 |
| Nitrofurantoin | 11 | $325 | $30 |
| Omeprazole | 15 | $263 | $18 |
| Pantoprazole | 14 | $261 | $19 |
| Gabapentin | 16 | $227 | $14 |
| Paroxetine | 15 | $215 | $14 |
| Finasteride | 15 | $198 | $13 |
| Lisinopril | 23 | $167 | $7 |
| Simvastatin | 22 | $140 | $6 |
| Sertraline | 14 | $127 | $9 |
| Famotidine | 15 | $90 | $6 |
| Amiodarone | 11 | $51 | $5 |
2021: 31 drugs
| Eliquis | 52 | $31,120 | $598 |
| Memantine | 21 | $2,837 | $135 |
| Rosuvastatin | 22 | $1,695 | $77 |
| Atorvastatin | 60 | $968 | $16 |
| Levothyroxine | 35 | $867 | $25 |
| Levetiracetam Er | 12 | $747 | $62 |
| Albuterol Sulfate Hfa | 12 | $705 | $59 |
| Tamsulosin | 25 | $649 | $26 |
| Metformin | 38 | $643 | $17 |
| Losartan | 33 | $588 | $18 |
| Pravastatin | 30 | $540 | $18 |
| Glipizide Er | 21 | $528 | $25 |
| Donepezil | 21 | $508 | $24 |
| Fluticasone Propionate | 13 | $481 | $37 |
| Fluoxetine | 29 | $400 | $14 |
| Celecoxib | 13 | $376 | $29 |
| Omeprazole | 19 | $351 | $18 |
| Finasteride | 18 | $306 | $17 |
| Metoprolol | 14 | $288 | $21 |
| Lisinopril | 45 | $287 | $6 |
| Amlodipine Besylate | 28 | $273 | $10 |
| Gabapentin | 28 | $207 | $7 |
| Paroxetine | 19 | $203 | $11 |
| Lovastatin | 13 | $183 | $14 |
| Sertraline | 16 | $174 | $11 |
| Simvastatin | 18 | $165 | $9 |
| Carvedilol | 14 | $146 | $10 |
| Famotidine | 11 | $98 | $9 |
| Hydrochlorothiazide | 13 | $73 | $6 |
| Prednisone | 14 | $70 | $5 |
| Furosemide | 12 | $61 | $5 |
2020: 27 drugs
| Eliquis | 32 | $21,774 | $680 |
| Memantine | 20 | $2,459 | $123 |
| Valsartan | 16 | $1,178 | $74 |
| Olmesartan Medoxomil | 12 | $1,144 | $95 |
| Levothyroxine | 38 | $938 | $25 |
| Atorvastatin | 46 | $763 | $17 |
| Fluoxetine | 24 | $704 | $29 |
| Tamsulosin | 23 | $550 | $24 |
| Donepezil | 19 | $483 | $25 |
| Losartan | 24 | $450 | $19 |
| Pravastatin | 15 | $425 | $28 |
| Omeprazole | 18 | $373 | $21 |
| Metformin | 23 | $331 | $14 |
| Lovastatin | 18 | $328 | $18 |
| Glipizide Er | 16 | $322 | $20 |
| Lisinopril | 36 | $301 | $8 |
| Simvastatin | 25 | $275 | $11 |
| Amlodipine Besylate | 21 | $246 | $12 |
| Finasteride | 16 | $231 | $14 |
| Gabapentin | 23 | $196 | $9 |
| Clopidogrel | 16 | $193 | $12 |
| Allopurinol | 12 | $154 | $13 |
| Carvedilol | 16 | $141 | $9 |
| Paroxetine | 14 | $132 | $9 |
| Famotidine | 12 | $74 | $6 |
| Furosemide | 11 | $70 | $6 |
| Hydrochlorothiazide | 14 | $49 | $4 |
2019: 34 drugs
| Eliquis | 25 | $15,695 | $628 |
| Levothyroxine | 73 | $2,114 | $29 |
| Carbidopa-Levodopa | 14 | $1,737 | $124 |
| Donepezil | 19 | $1,420 | $75 |
| Atorvastatin | 74 | $1,264 | $17 |
| Diclofenac | 16 | $1,108 | $69 |
| Gabapentin | 26 | $978 | $38 |
| Losartan | 46 | $814 | $18 |
| Fluoxetine | 24 | $805 | $34 |
| Amlodipine Besylate | 66 | $799 | $12 |
| Metoprolol | 19 | $728 | $38 |
| Pravastatin | 17 | $717 | $42 |
| Omeprazole | 23 | $699 | $30 |
| Bisoprolol | 15 | $610 | $41 |
| Valsartan | 11 | $482 | $44 |
| Losartan-Hydrochlorothiazide | 22 | $405 | $18 |
| Quetiapine | 20 | $398 | $20 |
| Lisinopril | 36 | $388 | $11 |
| Sertraline | 24 | $359 | $15 |
| Lovastatin | 16 | $324 | $20 |
| Clopidogrel | 20 | $322 | $16 |
| Terazosin | 12 | $311 | $26 |
| Tamsulosin | 20 | $304 | $15 |
| Benazepril | 21 | $271 | $13 |
| Digox | 11 | $265 | $24 |
| Simvastatin | 23 | $265 | $12 |
| Trazodone | 18 | $242 | $13 |
| Metformin | 17 | $241 | $14 |
| Mirtazapine | 15 | $228 | $15 |
| Carvedilol | 30 | $219 | $7 |
| Metformin Hcl Er | 15 | $173 | $12 |
| Glipizide Er | 14 | $123 | $9 |
| Prednisone | 16 | $75 | $5 |
| Hydrochlorothiazide | 12 | $48 | $4 |
2018: 65 drugs
| Eliquis | 26 | $14,823 | $570 |
| Xarelto | 15 | $7,395 | $493 |
| Premarin | 11 | $4,625 | $420 |
| Vesicare | 12 | $4,464 | $372 |
| Levothyroxine | 117 | $3,607 | $31 |
| Atorvastatin | 100 | $2,063 | $21 |
| Carbidopa-Levodopa | 24 | $1,882 | $78 |
| Metoprolol | 30 | $1,560 | $52 |
| Pravastatin | 30 | $1,398 | $47 |
| Synthroid | 22 | $1,329 | $60 |
| Fluoxetine | 29 | $1,202 | $41 |
| Duloxetine | 16 | $1,197 | $75 |
| Amlodipine Besylate | 113 | $1,114 | $10 |
| Losartan | 71 | $927 | $13 |
| Proair Hfa | 14 | $901 | $64 |
| Omeprazole | 43 | $867 | $20 |
| Clopidogrel | 46 | $840 | $18 |
| Valsartan | 27 | $824 | $31 |
| Rosuvastatin | 14 | $757 | $54 |
| Lovastatin | 24 | $718 | $30 |
| Lisinopril | 94 | $696 | $7 |
| Bisoprolol | 11 | $689 | $63 |
| Oxybutynin Chloride Er | 12 | $682 | $57 |
| Losartan-Hydrochlorothiazide | 50 | $642 | $13 |
| Olanzapine Odt | 12 | $632 | $53 |
| Simvastatin | 55 | $619 | $11 |
| Tamsulosin | 19 | $610 | $32 |
| Temazepam | 13 | $554 | $43 |
| Sertraline | 48 | $540 | $11 |
| Gabapentin | 27 | $529 | $20 |
| Metformin | 51 | $431 | $8 |
| Montelukast | 18 | $390 | $22 |
| Metformin Hcl Er | 19 | $325 | $17 |
| Trazodone | 26 | $311 | $12 |
| Fluticasone Propionate | 19 | $296 | $16 |
| Pioglitazone | 11 | $296 | $27 |
| Benazepril | 29 | $294 | $10 |
| Dilt-Xr | 14 | $286 | $20 |
| Penicillin V | 12 | $248 | $21 |
| Pantoprazole | 16 | $246 | $15 |
| Donepezil | 17 | $240 | $14 |
| Allopurinol | 13 | $236 | $18 |
| Digoxin | 12 | $232 | $19 |
| Mirtazapine | 23 | $224 | $10 |
| Carvedilol | 29 | $223 | $8 |
| Diclofenac | 11 | $212 | $19 |
| Potassium Chloride | 12 | $206 | $17 |
| Diltiazem 24hr Er (Cd) | 14 | $206 | $15 |
| Escitalopram | 20 | $202 | $10 |
| Atenolol | 13 | $195 | $15 |
| Metoprolol | 18 | $178 | $10 |
| Zolpidem | 18 | $165 | $9 |
| Hydrocodone-Acetaminophen | 14 | $161 | $12 |
| Glipizide | 19 | $155 | $8 |
| Alprazolam | 15 | $154 | $10 |
| Citalopram Hbr | 17 | $145 | $9 |
| Finasteride | 15 | $139 | $9 |
| Hydrochlorothiazide | 20 | $134 | $7 |
| Terazosin | 12 | $131 | $11 |
| Triamterene-Hydrochlorothiazid | 11 | $127 | $12 |
| Anastrozole | 14 | $124 | $9 |
| Furosemide | 23 | $109 | $5 |
| Prednisone | 12 | $79 | $7 |
| Lorazepam | 19 | $78 | $4 |
| Tramadol | 18 | $53 | $3 |
2017: 85 drugs
| Eliquis | 30 | $16,252 | $542 |
| Xarelto | 29 | $12,011 | $414 |
| Lyrica | 23 | $11,481 | $499 |
| Januvia | 21 | $11,412 | $543 |
| Namenda Xr | 17 | $11,141 | $655 |
| Lantus | 22 | $7,160 | $325 |
| Flovent Hfa | 12 | $6,236 | $520 |
| Metformin Hcl Er | 20 | $5,077 | $254 |
| Premarin | 11 | $4,357 | $396 |
| Levothyroxine | 136 | $3,950 | $29 |
| Atorvastatin | 128 | $2,690 | $21 |
| Benicar Hct | 11 | $2,403 | $218 |
| Carbidopa-Levodopa | 27 | $1,822 | $67 |
| Metoprolol | 23 | $1,662 | $72 |
| Rosuvastatin | 18 | $1,630 | $91 |
| Pravastatin | 41 | $1,358 | $33 |
| Synthroid | 21 | $1,291 | $61 |
| Tamsulosin | 38 | $1,193 | $31 |
| Amiodarone | 15 | $1,145 | $76 |
| Amlodipine Besylate | 145 | $1,025 | $7 |
| Baclofen | 17 | $1,009 | $59 |
| Proair Hfa | 13 | $1,008 | $78 |
| Bisoprolol | 16 | $934 | $58 |
| Celecoxib | 12 | $882 | $73 |
| Clopidogrel | 40 | $792 | $20 |
| Valsartan | 28 | $751 | $27 |
| Omeprazole | 39 | $719 | $18 |
| Pantoprazole | 41 | $658 | $16 |
| Lisinopril | 95 | $655 | $7 |
| Fluoxetine | 24 | $621 | $26 |
| Acetazolamide | 12 | $609 | $51 |
| Losartan | 54 | $601 | $11 |
| Lovastatin | 16 | $586 | $37 |
| Mirtazapine | 34 | $582 | $17 |
| Quetiapine | 20 | $575 | $29 |
| Sertraline | 65 | $559 | $9 |
| Metformin | 57 | $551 | $10 |
| Simvastatin | 68 | $514 | $8 |
| Digoxin | 18 | $501 | $28 |
| Potassium Chloride | 17 | $464 | $27 |
| Losartan-Hydrochlorothiazide | 34 | $432 | $13 |
| Isosorbide Mononitrate Er | 18 | $428 | $24 |
| Venlafaxine | 11 | $419 | $38 |
| Diclofenac | 12 | $409 | $34 |
| Gabapentin | 17 | $402 | $24 |
| Fluticasone Propionate | 21 | $388 | $18 |
| Hydralazine | 13 | $383 | $29 |
| Benazepril | 37 | $349 | $9 |
| Diltiazem 24hr Er | 16 | $340 | $21 |
| Zolpidem | 22 | $334 | $15 |
| Klor-Con 8 | 24 | $326 | $14 |
| Furosemide | 56 | $317 | $6 |
| Donepezil | 30 | $310 | $10 |
| Warfarin | 12 | $272 | $23 |
| Risperidone | 19 | $269 | $14 |
| Terazosin | 21 | $267 | $13 |
| Escitalopram | 26 | $261 | $10 |
| Carvedilol | 28 | $240 | $9 |
| Levetiracetam | 16 | $238 | $15 |
| Alprazolam | 25 | $238 | $10 |
| Trazodone | 34 | $232 | $7 |
| Montelukast | 13 | $231 | $18 |
| Lorazepam | 24 | $228 | $9 |
| Pioglitazone | 13 | $222 | $17 |
| Atenolol | 21 | $215 | $10 |
| Hydrocodone-Acetaminophen | 23 | $214 | $9 |
| Nortriptyline | 13 | $212 | $16 |
| Hydrochlorothiazide | 42 | $210 | $5 |
| Metoprolol | 22 | $209 | $10 |
| Allopurinol | 12 | $196 | $16 |
| Dorzolamide | 12 | $191 | $16 |
| Finasteride | 16 | $183 | $11 |
| Citalopram Hbr | 19 | $159 | $8 |
| Alendronate | 16 | $158 | $10 |
| Imipramine | 12 | $149 | $12 |
| Azithromycin | 16 | $119 | $7 |
| Venlafaxine Hcl Er | 11 | $119 | $11 |
| Tramadol | 31 | $118 | $4 |
| Lisinopril-Hydrochlorothiazide | 18 | $88 | $5 |
| Anastrozole | 11 | $84 | $8 |
| Glipizide | 15 | $81 | $5 |
| Estradiol | 14 | $78 | $6 |
| Ciprofloxacin | 14 | $65 | $5 |
| Meloxicam | 20 | $59 | $3 |
| Diazepam | 15 | $39 | $3 |
2016: 68 drugs
| Xarelto | 26 | $10,770 | $414 |
| Lyrica | 16 | $9,289 | $581 |
| Vesicare | 15 | $5,276 | $352 |
| Lantus | 15 | $3,791 | $253 |
| Levothyroxine | 128 | $3,186 | $25 |
| Atorvastatin | 118 | $2,170 | $18 |
| Celecoxib | 20 | $2,007 | $100 |
| Valsartan | 19 | $1,739 | $92 |
| Amlodipine-Valsartan | 12 | $1,433 | $119 |
| Proair Hfa | 18 | $1,270 | $71 |
| Amlodipine Besylate | 113 | $1,105 | $10 |
| Zolpidem | 28 | $1,011 | $36 |
| Metoprolol | 20 | $952 | $48 |
| Bupropion Hcl Sr | 11 | $925 | $84 |
| Omeprazole | 61 | $923 | $15 |
| Quetiapine | 32 | $828 | $26 |
| Clopidogrel | 34 | $772 | $23 |
| Fluoxetine | 35 | $770 | $22 |
| Pravastatin | 25 | $744 | $30 |
| Lisinopril | 106 | $733 | $7 |
| Bisoprolol | 16 | $663 | $41 |
| Tamsulosin | 33 | $620 | $19 |
| Propranolol Hcl Er | 12 | $619 | $52 |
| Gabapentin | 25 | $606 | $24 |
| Hydrocodone-Acetaminophen | 29 | $605 | $21 |
| Lorazepam | 35 | $580 | $17 |
| Losartan | 60 | $544 | $9 |
| Duloxetine | 11 | $536 | $49 |
| Montelukast | 24 | $515 | $21 |
| Lovastatin | 22 | $503 | $23 |
| Potassium Chloride | 12 | $479 | $40 |
| Mirtazapine | 23 | $478 | $21 |
| Losartan-Hydrochlorothiazide | 33 | $453 | $14 |
| Metformin | 52 | $450 | $9 |
| Alprazolam | 33 | $449 | $14 |
| Simvastatin | 55 | $446 | $8 |
| Donepezil | 24 | $427 | $18 |
| Pantoprazole | 32 | $398 | $12 |
| Torsemide | 17 | $389 | $23 |
| Isosorbide Mononitrate Er | 18 | $359 | $20 |
| Escitalopram | 16 | $340 | $21 |
| Sertraline | 33 | $323 | $10 |
| Triamterene-Hydrochlorothiazid | 19 | $320 | $17 |
| Furosemide | 60 | $318 | $5 |
| Prednisone | 26 | $314 | $12 |
| Tramadol | 58 | $311 | $5 |
| Klor-Con 8 | 19 | $311 | $16 |
| Fluticasone Propionate | 16 | $308 | $19 |
| Metoprolol | 38 | $301 | $8 |
| Trazodone | 32 | $245 | $8 |
| Carvedilol | 21 | $222 | $11 |
| Alendronate | 13 | $211 | $16 |
| Azithromycin | 20 | $184 | $9 |
| Estradiol | 12 | $182 | $15 |
| Hydrochlorothiazide | 38 | $173 | $5 |
| Warfarin | 18 | $168 | $9 |
| Benazepril | 24 | $162 | $7 |
| Metformin Hcl Er | 26 | $156 | $6 |
| Terazosin | 12 | $128 | $11 |
| Finasteride | 11 | $126 | $11 |
| Venlafaxine Hcl Er | 11 | $114 | $10 |
| Meloxicam | 27 | $111 | $4 |
| Acetazolamide | 12 | $108 | $9 |
| Levofloxacin | 13 | $103 | $8 |
| Ciprofloxacin | 15 | $97 | $6 |
| Citalopram Hbr | 11 | $62 | $6 |
| Sulfamethoxazole-Trimethoprim | 13 | $51 | $4 |
| Diazepam | 18 | $46 | $3 |
2015: 47 drugs
| Spiriva | 13 | $4,049 | $311 |
| Valsartan | 11 | $2,090 | $190 |
| Oxycodone-Acetaminophen | 27 | $1,688 | $63 |
| Atorvastatin | 63 | $1,248 | $20 |
| Levothyroxine | 48 | $1,231 | $26 |
| Proair Hfa | 22 | $1,129 | $51 |
| Celecoxib | 12 | $1,068 | $89 |
| Synthroid | 23 | $969 | $42 |
| Zolpidem | 27 | $723 | $27 |
| Hydrocodone-Acetaminophen | 29 | $598 | $21 |
| Propranolol Hcl Er | 11 | $587 | $53 |
| Azelastine | 11 | $569 | $52 |
| Potassium Chloride | 12 | $549 | $46 |
| Amlodipine Besylate | 59 | $428 | $7 |
| Lisinopril | 68 | $427 | $6 |
| Oxybutynin Chloride Er | 11 | $427 | $39 |
| Levofloxacin | 17 | $417 | $25 |
| Gabapentin | 20 | $407 | $20 |
| Losartan | 46 | $395 | $9 |
| Fluticasone Propionate | 33 | $353 | $11 |
| Pantoprazole | 25 | $351 | $14 |
| Pravastatin | 14 | $348 | $25 |
| Omeprazole | 21 | $313 | $15 |
| Prednisone | 18 | $297 | $16 |
| Hydrochlorothiazide | 33 | $288 | $9 |
| Clopidogrel | 15 | $287 | $19 |
| Triamterene-Hydrochlorothiazid | 11 | $266 | $24 |
| Metoprolol | 25 | $261 | $10 |
| Montelukast | 19 | $260 | $14 |
| Escitalopram | 19 | $259 | $14 |
| Simvastatin | 39 | $257 | $7 |
| Bisoprolol | 16 | $237 | $15 |
| Losartan-Hydrochlorothiazide | 19 | $222 | $12 |
| Sertraline | 11 | $204 | $19 |
| Atenolol | 19 | $185 | $10 |
| Alprazolam | 27 | $167 | $6 |
| Klor-Con 8 | 12 | $166 | $14 |
| Trazodone | 28 | $160 | $6 |
| Donepezil | 15 | $158 | $11 |
| Metformin | 14 | $157 | $11 |
| Lorazepam | 20 | $141 | $7 |
| Benazepril | 15 | $115 | $8 |
| Clonazepam | 16 | $113 | $7 |
| Ciprofloxacin | 23 | $103 | $4 |
| Azithromycin | 15 | $96 | $6 |
| Tramadol | 17 | $86 | $5 |
| Furosemide | 16 | $60 | $4 |
2014: 9 drugs
| Oxycodone-Acetaminophen | 14 | $678 | $48 |
| Levofloxacin | 16 | $313 | $20 |
| Hydrocodone-Acetaminophen | 13 | $201 | $15 |
| Fluticasone Propionate | 12 | $146 | $12 |
| Prednisone | 11 | $139 | $13 |
| Amlodipine Besylate | 11 | $117 | $11 |
| Lisinopril | 14 | $112 | $8 |
| Trazodone | 11 | $107 | $10 |
| Clonazepam | 11 | $78 | $7 |
Money from drug and device companies
$452 in 2025
| 2025 | 10 | 20 | None | $452 |
| 2024 | 7 | 8 | None | $164 |
| 2023 | 7 | 10 | None | $219 |
| 2022 | 1 | 4 | None | $66 |
| 2021 | 1 | 1 | None | $27 |
| 2020 | 1 | 1 | None | $11 |
| 2019 | 2 | 3 | None | $31 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Amgen | Evenity | $106 | 4 payments
|
| Exact Sciences | The Cologuard Plus Collection Kit | $84 | 4 payments
|
| Lilly USA | Mounjaro | $51 | 3 payments
|
| Philips North America | Vest Therapy Und | $42 | 2 payments
|
| Novo Nordisk | None | $42 | 2 payments
|
| Scpharmaceuticals | Furoscix | $30 | 1 payment
|
See all 20 published payments
| Scpharmaceuticals | Meals · 2025-11-17 | Furoscix | $30 |
| Pfizer | Meals · 2025-10-18 | Paxlovid | $23 |
| Amgen | Meals · 2025-10-14 | Evenity | $27 |
| Exact Sciences | Meals · 2025-10-13 | The Cologuard Plus Collection Kit | $22 |
| Amgen | Meals · 2025-10-06 | Evenity | $27 |
| Lilly USA | Meals · 2025-08-18 | Mounjaro | $19 |
| Exact Sciences | Meals · 2025-07-14 | The Cologuard Plus Collection Kit | $21 |
| Exact Sciences | Meals · 2025-05-23 | The Cologuard Plus Collection Kit | $19 |
| Amgen | Meals · 2025-05-16 | Evenity | $28 |
| Lilly USA | Meals · 2025-05-12 | Zepbound | $15 |
| Novo Nordisk | Meals · 2025-05-01 | None | $21 |
| Edwards Lifesciences | Meals · 2025-04-25 | Sapien 3 Ultra Resilia | $19 |
| Exact Sciences | Meals · 2025-04-14 | The Cologuard Plus Collection Kit | $21 |
| Seqirus USA | Meals · 2025-04-05 | Fluad | $29 |
| Novo Nordisk | Meals · 2025-03-20 | None | $21 |
| Lilly USA | Meals · 2025-03-14 | Mounjaro | $16 |
| Amgen | Meals · 2025-03-10 | Evenity | $25 |
| Heartflow | Meals · 2025-02-28 | Ffrct | $25 |
| Philips North America | Meals · 2025-02-03 | Vest Therapy Und | $19 |
| Philips North America | Meals · 2025-01-22 | Vest Therapy Und | $24 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $164
| Pfizer | Paxlovid | $36 | 2 payments
|
| Amgen | Evenity | $25 | 1 payment
|
| GlaxoSmithKline | Arexvy | $23 | 1 payment
|
| Bausch Health US | Aplenzin | $23 | 1 payment
|
| Novo Nordisk | None | $22 | 1 payment
|
| Edwards Lifesciences | Sapien 3 Ultra Resilia | $18 | 1 payment
|
| Lilly USA | Mounjaro | $17 | 1 payment
|
2023: $219
| Pfizer | Nurtec Odt | $71 | 3 payments
|
| Exact Sciences | Cologuard Collection Kit | $35 | 2 payments
|
| GlaxoSmithKline | Shingrix | $29 | 1 payment
|
| Sanofi Pasteur | Fluzone High-Dose | $25 | 1 payment
|
| Novo Nordisk | None | $24 | 1 payment
|
| Lilly USA | Mounjaro | $22 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Breztri | $15 | 1 payment
|
2022: $66
| Biohaven Pharmaceutical Holding Company | Nurtec Odt | $66 | 4 payments
|
2021: $27
| Alfasigma USA | None | $27 | 1 payment
|
2020: $11
| Sunovion Pharmaceuticals | Latuda | $11 | 1 payment
|
2019: $31
| Sunovion Pharmaceuticals | Latuda | $18 | 2 payments
|
| Sanofi Pasteur | Fluzone Quadrivalent | $13 | 1 payment
|
Professional record
- NPI
- 1952370900
- Licence
- CA A78098California A78098: Current · expires 2027-09-30
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Medicaid ID
- CA 00A780980
- Taxonomy
- Internal medicine (207R00000X)
- Mailing address
- 11126 Linda Vista Dr, Cupertino, CA, 95014
- NPI first listed
- 2006-03-14
- NPI last updated
- 2016-02-24
This is when the NPI record was last certified, not a medical board exam.